Ranked #8,519 of 8,699 institutional investors
M28 Capital Management LP
Stamford, CT
$28.5M
US stock portfolio at live prices · today +$126K (+0.44%)
Live prices, last trade 10:34 AM ET
- Value at quarter end (Q3 2026)
- $36.0M
- Change from Q2 2026
- −$11.1M (−23.57%)
- Positions
- 6 · 0 new, 0 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$2.0M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesWVE 43.8%TGTX 20.1%IVVD 14.9%SLN 7.03%ARWR 5.56%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| WVE Wave Life Sciences, Inc. | 4,588,284 | $12.5M | 43.8% | Unchanged |
| TGTX TG Therapeutics, Inc. | 88,354 | $5.7M | 20.1% | Unchanged |
| IVVD Invivyd, Inc. | 9,248,250 | $4.3M | 14.9% | Unchanged |
| SLN Silence Therapeutics plc | 101,203 | $2.0M | 7.03% | Unchanged |
| ARWR Arrowhead Pharmaceuticals, Inc. | 36,851 | $1.6M | 5.56% | Unchanged |
| RCKT Rocket Pharmaceuticals, Inc. | 210,871 | $444K | 1.56% | Unchanged |